Utilization of high-fidelity simulation for medical student and resident education of allergic-immunologic emergencies

Anaphylaxis is an acute, systemic hypersensitivity reaction with an estimated lifetime prevalence of 0.05-2%.1 Epinephrine is the first line treatment while other therapies such as anti-histamines and systemic steroids have limited evidence for the acute management of anaphylaxis. Anaphylaxis is frequently under-diagnosed and not treated with epinephrine in health care settings.2-3 Delayed administration of epinephrine represents a significant risk factor for severe and fatal anaphylaxis.4-5 Furthermore, there are wide variations in epinephrine auto-injector (EAI) administration technique among patients, caregivers, and healthcare professionals alike.

https://ift.tt/2EarxJ4